Screener
Rhythm Pharmaceuticals, Inc. RYTM Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 26,622 | 26,133 |
| Total current assets | 430,090 | 466,916 |
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
| Other long-term assets | 2,518 | 3,286 |
| Total assets | $442,316 | $480,196 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported operating lease ROU assets of $2.94M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 12.8% year-over-year, from $3.37M to $2.94M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 11.0% compound annual growth rate (CAGR), from $1.81M to $3.05M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude